David Hendlin
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 10
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 11
- Microbial Natural Products and Biosynthesis 7
- Fungal Biology and Applications 5
- Microbiology top 5%
- Organic Chemistry top 5%
-
- Phenothiazines and Benzothiazines Synthesis and Activities 6
- Microbial Metabolic Engineering and Bioproduction 6
- Biochemical and Molecular Research 5
-
- Antimicrobial Resistance in Staphylococcus 4
- Co-authors
- E. O. StapleyH. B. WoodruffH. WallickA. Kathrine MillerM. JacksonSebastian HernandezS. MochalesThomas W. Miller
- Journals
- Journal of Bacteriology (14 papers)Antimicrobial Agents and Chemotherapy (8 papers)The Journal of Antibiotics (3 papers)
- Partner nations
- United StatesGermany
In The Last Decade
David Hendlin
59 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Medicine 637
- Pharmacology 880
- Microbiology 19
- Applied Microbiology and Biotechnology 46
- Organic Chemistry 522
Countries citing papers authored by David Hendlin
This map shows the geographic impact of David Hendlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hendlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hendlin more than expected).
Fields of papers citing papers by David Hendlin
This network shows the impact of papers produced by David Hendlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hendlin. The network helps show where David Hendlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Hendlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 36 | |
| 2 | 1979 | 4 | |
| 3 | Thienamycin, a new .BETA.-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.breakdown → | 1979 | 388 |
| 4 | 1977 | 47 | |
| 5 | 1972 | 11 | |
| 6 | 1971 | 48 | |
| 7 | Phosphonomycin. V. Evaluation in mice. | 1969 | 9 |
| 8 | Phosphonomycin, a New Antibiotic Produced by Strains of Streptomycesbreakdown → | 1969 | 473 |
| 9 | 1966 | 19 | |
| 10 | 1965 | 36 | |
| 11 | 1963 | 37 | |
| 12 | 1962 | 4 | |
| 13 | 1962 | 5 | |
| 14 | 1960 | 13 | |
| 15 | 1959 | 12 | |
| 16 | 1954 | 5 | |
| 17 | 1953 | 20 | |
| 18 | 1953 | 3 | |
| 19 | 1951 | 9 | |
| 20 | 1951 | 8 |
About David Hendlin
David Hendlin is a scholar working on Molecular Medicine, Pharmacology, Microbiology, Clinical Biochemistry and Molecular Biology, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (10 papers), Microbial Natural Products and Biosynthesis (7 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Microbial Metabolic Engineering and Bioproduction (6 papers), Biochemical and Molecular Research (5 papers), Fungal Biology and Applications (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Molecular Medicine (637 citations), Pharmacology (880 citations), Microbiology (19 citations), Applied Microbiology and Biotechnology (46 citations) and Organic Chemistry (522 citations). David Hendlin has collaborated with scholars based in United States and Germany. Frequent co-authors include E. O. Stapley, H. B. Woodruff, H. Wallick, A. Kathrine Miller, M. Jackson, Sebastian Hernandez, S. Mochales, Thomas W. Miller, Frederick M. Kahan and J.M. Mata. Their work appears in journals such as Journal of Bacteriology, Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Chemotherapy and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.